abana

mixture of Terminalia arjuna (30), Withania somnifera (20), Nepeta hindostana (20), Asparagus racemosus (10), Tinospora cordifolia (10), Centella asiatica (10), Phyllanthus emblica (10), Boerhaavia diffusa (10), Convolvulus (10), Ocimum sanctum (10), Nardostachys (10), Piper longum (10), Carum copticum (10), Zingiber officinale (10), Eclipta alba (10), Cyperus rotundus (5), Acorus calamus (5), Embelia ribes (5), Syzygium aromaticum (5), Celastrus (5), Santalum (5), Elettaria cardamomum (5), Foeniculum (5), Rosa (5), Cinnamomum cassia (5), Crocus sativus (2), Aloe (1), Daucus carota (1), Nelumbium (1), Punica granatum (1), Pyrus malus (1)

Networked: 7 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Godavarthi, Ashok: 1 article (04/2010)
2.	Nandakumar, Krishna S: 1 article (04/2010)
3.	Varma, R Sandeep: 1 article (04/2010)
4.	Vidyashankar, Satyakumar: 1 article (04/2010)
5.	Baliga, M S: 1 article (12/2004)
6.	Jagetia, G C: 1 article (12/2004)
7.	Reddy, R: 1 article (12/2004)
8.	Ulloor, J N: 1 article (12/2004)
9.	Venkatesh, P: 1 article (12/2004)
10.	Aruna, R: 1 article (06/2003)

Related Diseases

1.	Hypertension (High Blood Pressure) 11/01/1990 - "Twenty-five patients with ischemic heart disease (IHD) and 25 patients with IHD and mild hypertension (HTN) were enrolled in a double-blind, placebo controlled study of Abana. " 03/01/1990 - "Double blind comparative trial of Abana and methyldopa for monotherapy of hypertension in Indian patients." 03/01/1990 - "A double-blind, parallel group study was conducted in 43 Indian men and women suffering from hypertension to evaluate the antihypertensive effect of Abana and compare it with that of methyldopa (M-DOPA). "
2.	Atherosclerosis 07/01/1993 - "An experimental, placebo-controlled study with rabbits was conducted to determine the role of Abana, an Ayurvedic preparation, on atherosclerosis. " 07/01/1993 - "These findings substantiate the possible role of Abana in the reduction, prevention and reversal of atherosclerosis." 07/01/1993 - "Influence of Abana on experimental atherogenesis in hypercholesterolemic rabbits."
3.	Myocardial Ischemia (Ischemic Heart Diseases) 11/01/1990 - "Abana seems to reduce preload and afterload and improve diastolic function and pump function, which may be responsible for the beneficial effects of Abana in ischemic heart disease." 11/01/1990 - "Effect of Abana on ventricular function in ischemic heart disease." 11/01/1990 - "Twenty-five patients with ischemic heart disease (IHD) and 25 patients with IHD and mild hypertension (HTN) were enrolled in a double-blind, placebo controlled study of Abana. "
4.	Myocardial Infarction 08/01/2000 - "Effect of abana an ayurvedic formulation, on lipid peroxidation in experimental myocardial infarction in rats." 08/01/2000 - "Abana, produced a marked reversal of these metabolic changes related to myocardial infarction induced by isoproterenol. " 08/01/2000 - "The present study was conducted to elucidate the antioxidant role of an ayurvedic formulation Abana in isoproterenol induced myocardial infarction in rats. "
5.	Hyperlipidemias (Hyperlipidemia) 04/01/2010 - "The present study investigated the effect of water-soluble compounds in Abana (WSCA), a polyherbal drug formulation traditionally used in India for the treatment of hyperlipidemia, on lipid metabolism in HepG2 cells. "

Related Drugs and Biologics

1.	Methyldopa (Aldomet)
2.	Isoproterenol (Isoprenaline)
3.	Dihydroxyphenylalanine (Dopa)
4.	Antioxidants
5.	Antihypertensive Agents (Antihypertensives)
6.	Plant Preparations (Preparation, Plant)